(115) used the PKC inhibitor Go6976 or a PKCα gene defect to block the biological activity of PKCα in PD mice, resulting in alleviation of F4/80-positive macrophage invasion, peritoneal fibrosis, and neovascularization. Here, PRKCA is linked to Peritoneal Fibrosis.